|
시장보고서
상품코드
1863963
생식 유전학 시장 : 기술별, 용도별, 시료유형별, 최종사용자별, 분석 수법별, 지역별Reproductive Genetics Market, By Technology, By Application, By Sample Type, By End User, By Methodology, By Geography |
||||||
생식 유전학 시장은 2025년에 73억 1,000만 달러, 2032년까지 166억 7,000만 달러에 이르고, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 12.5%로 성장할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 73억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 12.50% | 예측 금액(2032년) | 166억 7,000만 달러 |
세계적인 생식 유전학 시장은 의료 산업 전체에서 빠르게 진화하고 있는 분야로, 생식 건강과 불임 치료 결과를 평가하기 위해 고안된 고급 유전자 검사 및 스크리닝 기술을 포함하고 있습니다.
이 전문 시장은 의료 제공업체, 불임 치료 클리닉, 환자가 생식 계획, 임신 관리 및 유전 위험 평가에 대한 정보를 기반으로 의사 결정을 내릴 수 있도록 하는 유전자 분석 서비스 및 제품에 중점을 둡니다. 생식 유전학은 생식의 성공과 자손의 건강에 영향을 미칠 수 있는 염색체 이상, 유전성 질환, 유전성 질환을 확인하기 위해 최첨단 분자진단, 유전체 시퀀싱 기술, 바이오인포매틱스 플랫폼을 통합하고 있습니다.
이 시장은 착상 전 유전자 검사(PGT), 비침습적 출생 전 검사(NIPT), 보인자 스크리닝, 유전 상담 서비스 등 다양한 조사 기법을 포함하고 있습니다. 세계 의료 시스템이 맞춤형 의료 및 예방 의료를 점점 더 중시하고 있는 가운데, 생식 유전학은 현대 불임 치료 및 출생 전 치료 프로토콜에서 중요한 요소로 부상하고 있습니다.
시장 역학
세계의 생식 유전학 시장은 선진국 및 신흥 의료 시장의 확대를 지속적으로 촉진하는 몇 가지 강력한 요인에 의해 주로 견인되고 있습니다. 유전성 질환과 염색체 이상 유병률 증가와 세계적인 임산부의 고령화 동향이 함께 종합적인 유전자 스크리닝 서비스에 대한 수요가 크게 증가하고 있습니다.
특히 35세 이후 임신에서 노인 출산은 유전적 합병증의 위험을 증가시키기 때문에 의료 제공업체는 정기적인 유전자 검사 프로토콜을 시행할 것을 권장합니다. 차세대 시퀀싱(NGS), 마이크로어레이 분석 및 인공지능을 활용한 진단 플랫폼의 기술적 진보로 검사 정밀도가 크게 향상되었으며 비용과 소요 시간이 줄어들었습니다. 이를 통해 보다 광범위한 환자층이 이러한 서비스를 쉽게 이용할 수 있습니다.
의료 종사자와 환자 모두에서 조기 유전자 검출의 이점에 대한 인식이 높아짐에 따라 불임 치료 클리닉과 의료기관 전체의 도입률 향상을 촉진하고 있습니다. 그러나 진보된 유전 검사 절차와 관련된 비용이 많이 드는 현저한 제약 요인이 존재하며 개발 도상 지역의 환자와 종합적인 보험 적용을 받지 않은 환자에게 접근이 제한될 수 있습니다.
각국의 규제 복잡성과 승인 프로세스의 차이는 신기술 시장 진입을 방해하고 제품 출시 지연을 초래할 수 있습니다. 게다가, 유전자차별이나 유전자 정보의 프라이버시에 관한 문제를 포함한 유전자 검사를 둘러싼 윤리적 우려가, 특정의 환자층에 주저를 일으킬 우려가 있습니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 생식 유전학 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모·CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 생식 유전학 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개변수를 기반으로 게재됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계 생식 유전학 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 생식 유전학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병·인수(M&A) 시나리오
- 업계 동향
제4장 세계의 생식 유전학 시장 : 기술별(2020-2032년)
- 소개
- 착상 전 유전자 검사(PGT)
- 보인자 스크리닝
- 출생 전 유전자 검사
- 신생아 유전자 검사
제5장 세계의 생식 유전학 시장 : 용도별(2020-2032년)
- 소개
- 불임 치료와 체외수정(IVF) 프로그램
- 유전성 질환 위험 평가
- 염색체 이상 검출
- 태아 건강 스크리닝
- 유전성 질환의 진단
- 재발성 유산의 조사
제6장 세계의 생식 유전학 시장 : 제품 유형별(2020-2032년)
- 소개
- 기기 및 시스템
- 시퀀서
- PCR 시스템
- 마이크로어레이 플랫폼
- 소모품 및 시약
- DNA 추출 키트
- 증폭 시약
- 하이브리드화 프로브
- 소프트웨어 및 서비스
- 유전자 데이터 분석 툴
- 상담 및 해석 서비스
제7장 세계의 생식 유전학 시장 : 시료유형별(2020-2032년)
- 소개
- 배아
- 양수
- 모체혈
- 구강 스와브
- 제대혈
제8장 세계의 생식 유전학 시장 : 최종 사용자별(2020-2032년)
- 소개
- 불임 치료 클리닉 및 체외수정(IVF) 센터
- 병원 및 진단실험실
- 연구 및 학술기관
- 유전 상담 센터
제9장 세계의 생식 유전학 시장 : 분석 수법별(2020-2032년)
- 소개
- 차세대 시퀀싱(NGS)
- 중합효소 연쇄반응(PCR)
- 형광 제자리 혼성화(FISH)
- 비교 유전체 하이브리드화(CGH)
- 마이크로어레이 분석
제10장 세계의 생식 유전학 시장 : 지역별(2020-2032년)
- 소개
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN
- Agilent Technologies
- Revvity(PerkinElmer)
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- MGI Tech
- CooperSurgical
- Hamilton Thorne
- Vitrolife
- Takara Bio
- Promega Corporation
제12장 애널리스트의 제안
- Wheel of Fortune
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제13장 참고문헌과 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 7.31 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 12.50% | 2032 Value Projection: | USD 16.67 Bn |
The global reproductive genetics market represents a rapidly evolving segment within the broader healthcare industry, encompassing advanced genetic testing and screening technologies designed to assess reproductive health and fertility outcomes.
This specialized market focuses on genetic analysis services and products that help healthcare providers, fertility clinics, and patients make informed decisions regarding reproductive planning, pregnancy management, and genetic risk assessment. Reproductive genetics integrates cutting-edge molecular diagnostics, genomic sequencing technologies, and bioinformatics platforms to identify chromosomal abnormalities, genetic disorders, and hereditary conditions that may impact reproductive success or offspring health.
The market encompasses various testing methodologies including preimplantation genetic testing (PGT), non-invasive prenatal testing (NIPT), carrier screening, and genetic counseling services. As healthcare systems worldwide increasingly prioritize personalized medicine and preventive care, reproductive genetics has emerged as a critical component in modern fertility treatments and prenatal care protocols.
Market Dynamics
The global reproductive genetics market is primarily driven by several compelling factors that continue to fuel its expansion across developed and emerging healthcare markets. The increasing prevalence of genetic disorders and chromosomal abnormalities, combined with rising maternal age trends globally, has significantly heightened the demand for comprehensive genetic screening services.
Advanced maternal age, particularly pregnancies after 35 years, carries elevated risks of genetic complications, driving healthcare providers to recommend routine genetic testing protocols. Technological breakthroughs in next-generation sequencing (NGS), microarray analysis, and artificial intelligence-powered diagnostic platforms have substantially improved testing accuracy while reducing costs and turnaround times, making these services more accessible to broader patient populations.
Growing awareness among healthcare professionals and patients regarding the benefits of early genetic detection has fostered increased adoption rates across fertility clinics and healthcare institutions. However, the market faces notable restraints including high costs associated with advanced genetic testing procedures, which may limit accessibility for patients in developing regions or those without comprehensive insurance coverage.
Regulatory complexities and varying approval processes across different countries can impede market entry for new technologies and delay product launches. Additionally, ethical concerns surrounding genetic testing, including issues related to genetic discrimination and privacy of genetic information, may create hesitancy among certain patient demographics.
Key Features of the Study
- This report provides in-depth analysis of the global reproductive genetics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global reproductive genetics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies, Revvity (PerkinElmer), Bio-Rad Laboratories, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech, CooperSurgical, Hamilton Thorne, Vitrolife, Takara Bio, and Promega Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global reproductive genetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reproductive genetics market
Market Segmentation
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Preimplantation Genetic Testing (PGT)
- PGT-A (Aneuploidy)
- PGT-M (Monogenic Disorders)
- PGT-SR (Structural Rearrangements)
- Carrier Screening
- Targeted Mutation Panels
- Expanded Carrier Screening
- Prenatal Genetic Testing
- Non-Invasive Prenatal Testing (NIPT)
- Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
- Newborn Genetic Testing
- Whole Exome Sequencing
- Targeted Gene Panels
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Infertility and IVF Programs
- Genetic Disease Risk Assessment
- Chromosomal Abnormality Detection
- Fetal Health Screening
- Inherited Disorder Diagnosis
- Recurrent Pregnancy Loss Investigation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Instruments and Systems
- Sequencers
- PCR Systems
- Microarray Platforms
- Consumables and Reagents
- DNA Extraction Kits
- Amplification Reagents
- Hybridization Probes
- Software and Services
- Genetic Data Analysis Tools
- Counseling and Interpretation Services
- Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
- Embryo
- Amniotic Fluid
- Maternal Blood
- Buccal Swab
- Cord Blood
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Fertility Clinics and IVF Centers
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Genetic Counseling Centers
- Methodology Insights (Revenue, USD Bn, 2020 - 2032)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Microarray Analysis
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN
- Agilent Technologies
- Revvity (PerkinElmer)
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- MGI Tech
- CooperSurgical
- Hamilton Thorne
- Vitrolife
- Takara Bio
- Promega Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Reproductive Genetics Market, By Technology
- Global Reproductive Genetics Market, By Application
- Global Reproductive Genetics Market, By Product Type
- Global Reproductive Genetics Market, By Sample Type
- Global Reproductive Genetics Market, By End User
- Global Reproductive Genetics Market, By Methodology
- Global Reproductive Genetics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Reproductive Genetics Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Preimplantation Genetic Testing (PGT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- PGT-A (Aneuploidy)
- PGT-M (Monogenic Disorders)
- PGT-SR (Structural Rearrangements)
- Carrier Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Targeted Mutation Panels
- Expanded Carrier Screening
- Prenatal Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non-Invasive Prenatal Testing (NIPT)
- Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
- Newborn Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Whole Exome Sequencing
- Targeted Gene Panels
5. Global Reproductive Genetics Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Infertility and IVF Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Disease Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chromosomal Abnormality Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fetal Health Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inherited Disorder Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recurrent Pregnancy Loss Investigation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Reproductive Genetics Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Instruments and Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sequencers
- PCR Systems
- Microarray Platforms
- Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- DNA Extraction Kits
- Amplification Reagents
- Hybridization Probes
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Data Analysis Tools
- Counseling and Interpretation Services
7. Global Reproductive Genetics Market, By Sample Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Embryo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Amniotic Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Maternal Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Buccal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Reproductive Genetics Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Fertility Clinics and IVF Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Counseling Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Reproductive Genetics Market, By Methodology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Comparative Genomic Hybridization (CGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microarray Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Reproductive Genetics Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revvity (PerkinElmer)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MGI Tech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CooperSurgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hamilton Thorne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vitrolife
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
